Have a personal or library account? Click to login
In Vivo Efficacy of Bacillus velezensis Isolated from Korean Gochang Bokbunja Vinegar against Carbapenem-Resistant Klebsiella pneumoniae Infections Cover

In Vivo Efficacy of Bacillus velezensis Isolated from Korean Gochang Bokbunja Vinegar against Carbapenem-Resistant Klebsiella pneumoniae Infections

Open Access
|Dec 2022

References

  1. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evid Based Child Health. 2014; 9(3):584–671. https://doi.org/10.1002/ebch.1976
  2. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2010; (11):CD003048. https://doi.org/10.1002/14651858.CD003048.pub3
  3. Anwar F, Altayb HN, Al-Abbasi FA, Al-Malki AL, Kamal MA, Kumar V. Antiviral effects of probiotic metabolites on COVID-19. J Biomol Struct Dyn. 2021;39(11):4175–4184. https://doi.org/10.1080/07391102.2020.1775123
  4. Bahuguna A, Joe A, Kumar V, Lee JS, Kim SY, Moon JY, Cho SK, Cho H, Kim M. Study on the identification methods for effective microorganisms in commercially available organic agriculture materials. Microorganisms. 2020;8(10):1568. https://doi.org/10.3390/microorganisms8101568
  5. Brink AJ. Epidemiology of carbapenem-resistant Gram-negative infections globally. Curr Opin Infect Dis. 2019;32(6):609–616. https://doi.org/10.1097/QCO.0000000000000608
  6. CDC. Antibiotic resistance threats in the united states. Atlanta (USA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2019 [cited 2022 Aug 01]. Available from http://www.cdc.gov/drugresistance/Biggest-Threats.html
  7. Ceccarelli G, Statzu M, Santinelli L, Pinacchio C, Bitossi C, Cavallari EN, Vullo V, Scagnolari C, d’Ettorre G. Challenges in the management of hiv infection: update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS. Expert Opin Biol Ther. 2019;19(9):949–965. https://doi.org/10.1080/14712598.2019.1638907
  8. Cremonini F, Di Caro S, Santarelli L, Gabrielli M, Candelli M, Nista EC, Lupascu A, Gasbarrini G, Gasbarrini A. Probiotics in antibiotic-associated diarrhoea. Dig Liver Dis. 2002;34:S78–S80. https://doi.org/10.1016/S1590-8658(02)80171-2
  9. Czuprynski C, Faith N. Sodium bicarbonate enhances the severity of infection in neutropenic mice orally inoculated with Listeria monocytogenes EGD. Clin Vaccine Immunol. 2002;9(2):477–481. https://doi.org/10.1128/CDLI.9.2.477-481.2002
  10. De Luca F, Shoenfeld Y. The microbiome in autoimmune diseases. Clin Exp Immunol. 2019;195(1):74–85. https://doi.org/10.1111/cei.13158
  11. Dunlap CA. Taxonomy of registered Bacillus spp. strains used as plant pathogen antagonists. Biol Control. 2019;134:82–86. https://doi.org/10.1016/j.biocontrol.2019.04.011
  12. Fan B, Blom J, Klenk H-P, Borriss R. Bacillus amyloliquefaciens Bacillus velezensis, and Bacillus siamensis form an “operational group B. amyloliquefaciens” within the B. subtilis species complex. Front Microbiol. 2017;8:22. https://doi.org/10.3389/fmicb.2017.00022
  13. Fan B, Wang C, Song X, Ding X, Wu L, Wu H, Gao X, Borriss R. Bacillus velezensis FZB42 in 2018: the Gram-positive model strain for plant growth promotion and biocontrol. Front Microbiol. 2018; 9:2491. https://doi.org/10.3389/fmicb.2018.02491
  14. FAO/WHO. Report of a joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Cordoba (Argentina): World Health Organization/Food and Agriculture Organization of the United Nations; 2001.
  15. Huang CH, Huang L, Chang MT, Wu CP. Use of novel specific primers targeted to pheS and tuf gene for species and subspecies identification and differentiation of the Bacillus subtilis subsp. subtilis Bacillus amyloliquefaciens and Bacillus licheniformis. Afr J Microbiol Res. 2017a;11(7):264–270. https://doi.org/10.5897/AJMR2017.8434
  16. Huang FC, Lu YT, Liao YH. Beneficial effect of probiotics on Pseudomonas aeruginosa-infected intestinal epithelial cells through inflammatory IL-8 and antimicrobial peptide human beta-defensin-2 modulation. Innate Immun. 2020;26(7):592–600. https://doi.org/10.1177/1753425920959410
  17. Huang S, Cauty C, Dolivet A, Le Loir Y, Chen XD, Schuck P, Jan G, Jeantet R. Double use of highly concentrated sweet whey to improve the biomass production and viability of spray-dried probiotic bacteria. J Funct Foods. 2016;23:453–463. https://doi.org/10.1016/j.jff.2016.02.050
  18. Huang S, Vignolles M-L, Chen XD, Le Loir Y, Jan G, Schuck P, Jeantet R. Spray drying of probiotics and other food-grade bacteria: a review. Trends Food Sci Technol. 2017b;63:1–17. https://doi.org/10.1016/j.tifs.2017.02.007
  19. Khalid F, Khalid A, Fu Y, Hu Q, Zheng Y, Khan S, Wang Z. Potential of Bacillus velezensis as a probiotic in animal feed: a review. J Microbiol. 2021;59(7):627–633. https://doi.org/10.1007/s12275-021-1161-1
  20. Kopacz K, Phadtare S. Probiotics for the prevention of antibiotic-associated diarrhea. Healthcare. 2022;10(8):1450. https://doi.org/10.3390/healthcare10081450
  21. Kralik P, Ricchi M. A basic guide to real time PCR in microbial diagnostics: definitions, parameters, and everything. Front Micro-biol. 2017;8:108. https://doi.org/10.3389/fmicb.2017.00108
  22. Kulkarni RP. Probiotics leap from gut to blood. Sci Transl Med. 2019;11(521):eaaz9763. https://doi.org/10.1126/scitranslmed.aaz9763
  23. Kwon GH, Lee HA, Park JY, Kim JS, Lim J, Park CS, Kwon DY, Kim YS, Kim JH. Development of a RAPD-PCR method for identification of Bacillus species isolated from Cheonggukjang. Int J Food Microbiol. 2009;129(3):282–287. https://doi.org/10.1016/j.ijfoodmicro.2008.12.013
  24. Lee NK, Kim WS, Paik HD. Bacillus strains as human probiotics: characterization, safety, microbiome, and probiotic carrier. Food Sci Biotechnol. 2019;28(5):1297–1305. https://doi.org/10.1007/s10068-019-00691-9
  25. Lee Y, Seo H, Kim S, Rahim MDA, Yoon Y, Jung J, Lee S, Beom Ryu C, Song HY. Activity of Lactobacillus crispatus isolated from vaginal microbiota against Mycobacterium tuberculosis. J Microbiol. 2021;59(11):1019–1030. https://doi.org/10.1007/s12275-021-1332-0
  26. Li A, Wang Y, Pei L, Mehmood K, Li K, Qamar H, Iqbal M, Waqas M, Liu J, Li J. Influence of dietary supplementation with Bacillus velezensis on intestinal microbial diversity of mice. Microb Pathog. 2019; 136:103671. https://doi.org/10.1016/j.micpath.2019.103671
  27. Li HY, Zhou DD, Gan RY, Huang SY, Zhao CN, Shang A, Xu XY, Li HB. Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: a narrative review. Nutrients. 2021a;13(9):3211. https://doi.org/10.3390/nu13093211
  28. Li S, He P, Fan H, Liu L, Yin K, Yang B, Li Y, Huang SM, Li X, Zheng SJ. A real-time fluorescent reverse transcription quantitative PCR assay for rapid detection of genetic markers’ expression associated with fusarium wilt of banana biocontrol activities in Bacillus. J Fungi (Basel). 2021b;7(5):353. https://doi.org/10.3390/jof7050353
  29. Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis. 2017;215(suppl_1):S28–S36. https://doi.org/10.1093/infdis/jiw282
  30. Lutgring JD. Carbapenem-resistant Enterobacteriaceae: an emerging bacterial threat. Semin Diagn Pathol. 2019;36(3):182–186. https://doi.org/10.1053/j.semdp.2019.04.011
  31. Martín R, Langella P. Emerging health concepts in the probiotics field: streamlining the definitions. Front Microbiol. 2019;10:1047. https://doi.org/10.3389/fmicb.2019.01047
  32. Mazaya B, Hamzawy MA, Khalil MA, Tawkol WM, Sabit H. Immunomodulatory and antimicrobial efficacy of Lactobacilli against enteropathogenic infection of Salmonella typhi: in-vitro and in-vivo study. Int J Immunopathol Pharmacol. 2015;28(4):469–478. https://doi.org/10.1177/0394632015592099
  33. Morrill HJ, Pogue JM, Kaye KS, LaPlante KL. Treatment options for carbapenem-resistant Enterobacteriaceae infections. Open Forum Infect Dis. 2015;2(2):ofv050. https://doi.org/10.1093/ofid/ofv050
  34. Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, Han C, Bisignano C, Rao P, Wool E, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. https://doi.org/10.1016/S0140-6736(21)02724-0
  35. Oelschlaeger TA. Mechanisms of probiotic actions – a review. Int J Med Microbiol. 2010;300(1):57–62. https://doi.org/10.1016/j.ijmm.2009.08.005
  36. Pan YJ, Lin TL, Lin YT, Su PA, Chen CT, Hsieh PF, Hsu CR, Chen CC, Hsieh YC, Wang JT. Identification of capsular types in carbapenem-resistant Klebsiella pneumoniae strains by wzc sequencing and implications for capsule depolymerase treatment. Antimicrob Agents Chemother. 2015;59(2):1038–1047. https://doi.org/10.1128/AAC.03560-14
  37. Patel RM, Underwood MA. Probiotics and necrotizing enterocolitis. Semin Pediatr Surg. 2018;27(1):39–46. https://doi.org/10.1053/j.sempedsurg.2017.11.008
  38. Plaza-Diaz J, Gomez-Llorente C, Fontana L, Gil A. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics. World J Gastroenterol. 2014;20(42):15632. https://doi.org/10.3748/wjg.v20.i42.15632
  39. Potter RF, D’Souza AW, Dantas G. The rapid spread of carbapenem-resistant Enterobacteriaceae. Drug Resist Updat. 2016;29:30–46. https://doi.org/10.1016/j.drup.2016.09.002
  40. Rahim MA, Seo H, Kim S, Tajdozian H, Barman I, Lee Y, Lee S, Song HY. In vitro anti-tuberculosis effect of probiotic Lacticaseiba-cillus rhamnosus PMC203 isolated from vaginal microbiota. Sci Rep. 2022;12:8290. https://doi.org/10.1038/s41598-022-12413-z
  41. Sawatari Y, Hirano T, Yokota A. Development of food grade media for the preparation of Lactobacillus plantarum starter culture. J Gen Appl Microbiol. 2006;52(6):349–356. https://doi.org/10.2323/jgam.52.349
  42. Sheu CC, Chang YT, Lin SY, Chen YH, Hsueh PR. Infections caused by carbapenem-resistant Enterobacteriaceae: an update on therapeutic options. Front Microbiol. 2019;10:80. https://doi.org/10.3389/fmicb.2019.00080
  43. Sui Y, Liu J, Liu Y, Wang Y, Xiao Y, Gao B, Zhu D. In vitro probiotic characterization of Lactobacillus strains from fermented tangerine vinegar and their cholesterol degradation activity. Food Biosci. 2021; 39:100843. https://doi.org/10.1016/j.fbio.2020.100843
  44. Sulis G, Sayood S, Gandra S. Antimicrobial resistance in low-and middle-income countries: current status and future directions. Expert Rev Anti Infect Ther. 2022;20(2):147–160. https://doi.org/10.1080/14787210.2021.1951705
  45. Suva MA, Sureja VP, Kheni DB. Novel insight on probiotic Bacillus subtilis: mechanism of action and clinical applications. J Curr Res Sci Med 2016;2(2):65–72. https://doi.org/10.4103/2455-3069.198381
  46. Tajdozian H, Seo H, Kim S, Rahim MA, Lee S, Song HY. Efficacy of Lactobacillus fermentum isolated from the vagina of a healthy woman against carbapenem-resistant Klebsiella infections in vivo. J Microbiol Biotechnol. 2021;31(10):1383–1392. https://doi.org/10.4014/jmb.2103.03014
  47. Tilahun M, Kassa Y, Gedefie A, Ashagire M. Emerging carbapenem-resistant Enterobacteriaceae infection, its epidemiology and novel treatment options: a review. Infect Drug Resist. 2021;14: 4363–4374. https://doi.org/10.2147/IDR.S337611
  48. Urtasun R, Díaz-Gómez J, Araña M, Pajares MJ, Oneca M, Torre P, Jiménez M, Munilla G, Barajas M, Encío I. A combination of apple vinegar drink with Bacillus coagulans ameliorates high fat dietinduced body weight gain, insulin resistance and hepatic steatosis. Nutrients. 2020;12(9):2504. https://doi.org/10.3390/nu12092504
  49. Hemert S, Verwer J, Schütz B. Clinical studies evaluating effects of probiotics on parameters of intestinal barrier function. Adv Microbiol. 2013;3(2):212–221. https://doi.org/10.4236/aim.2013.32032
  50. VanderVeen BN, Sougiannis AT, Velazquez KT, Carson JA, Fan D, Murphy EA. The acute effects of 5 fluorouracil on skeletal muscle resident and infiltrating immune cells in mice. Front Physiol. 2020; 11:593468. https://doi.org/10.3389/fphys.2020.593468
  51. Wagner RD, Warner T, Roberts L, Farmer J, Balish E. Colonization of congenitally immunodeficient mice with probiotic bacteria. Infect Immun. 1997;65(8):3345–3351. https://doi.org/10.1128/iai.65.8.3345-3351.1997
  52. Williams NT. Probiotics. Am J Health Syst Pharm. 2010;67(6): 449–458. https://doi.org/10.2146/ajhp090168
  53. Ye M, Tang X, Yang R, Zhang H, Li F, Tao F, Li F, Wang Z. Characteristics and application of a novel species of Bacillus Bacillus velezensis. ACS Chem Biol. 2018;13(3):500–505. https://doi.org/10.1021/acschembio.7b00874
DOI: https://doi.org/10.33073/pjm-2022-051 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 553 - 562
Submitted on: Sep 9, 2022
|
Accepted on: Nov 3, 2022
|
Published on: Dec 12, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Fatemeh Ghorbanian, Hoonhee Seo, Hanieh Tajdozian, Youngkyoung Lee, MD Abdur Rahim, Sukyung Kim, Il-Yun Jung, Saebim Lee, Ho-Yeon Song, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.